Project 1: Influence of Apolipoprotein E Structure on Function: Apolipoprotein (apo-)E is a major mediator of lipoprotein metabolism via its interaction with members of the low density lipoprotein (LDL) receptor family. Polymorphic differences in the structure of apo-E have a major impact on apo-E-mediated lipoprotein metabolism. In addition, apo-E4, a structural isoform, is a major risk factor for Alzheimer's disease and other neurodegenerative disorders. Therefore, it is critically important to understand the influence of apo-E structure on its functions. The overall objective of this proposal focuses on the structure/function relationships of apo-E-related to lipoprotein metabolism, using x-ray crystallography as the primary structural tool. Previously, we introduced the concept of domain interaction-that the two structural domains of apo-E influence each other's functional properties-and determined how this interaction directs apo-E4's binding preference for very low density lipoproteins. In this proposal, we will extend our studies on domain interaction to elucidate the increased receptor-binding activity of apo- E4, to explore other aspects of domain interaction in both in vitro and in vivo model systems, and to gain a better understanding of the structure of lipid-bound apo-E. In addition, we will determine the structure of the LDL receptor and define the structure of the LDL receptor and define the molecular interface of the receptor and bound apo-E. We propose two specific aims to achieve these objectives.
In Aim 1, we will determine the x-ray structures of the LDL receptor and several physiologically relevant forms of apo-E. In addition to lipid-free forms, the structures of lipid- associated or detergent-treated apo-E will be determined to define the structural change that occurs when apo-E goes from a lipid-free, receptor- inactive state to a lipid-associated, receptor-active state.
In Aim 2, we will study the effect of domain interaction on receptor-binding function and test the hypothesis that a second distinct group of arginine residues within the hinge region of apo-E contributes to receptor-binding activity. The proposed studies will lead to new insights into how the structural differences in apo-E contribute to isoform-specific effects in lipoprotein metabolism, heart disease, and Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL041633-14
Application #
6564894
Study Section
Project Start
2002-02-01
Project End
2003-01-31
Budget Start
Budget End
Support Year
14
Fiscal Year
2002
Total Cost
$239,204
Indirect Cost
Name
J. David Gladstone Institutes
Department
Type
DUNS #
047120084
City
San Francisco
State
CA
Country
United States
Zip Code
94158
Svensson, Annika W; Casey, Patrick J; Young, Stephen G et al. (2006) Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function. Methods Enzymol 407:144-59
Schneider, Matthias; Witztum, Joseph L; Young, Stephen G et al. (2005) High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins. J Lipid Res 46:769-78
Ruiz, Jose; Kouiavskaia, Diana; Migliorini, Molly et al. (2005) The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J Lipid Res 46:1721-31
Sauer, Ines; Dunay, Ildiko R; Weisgraber, Karl et al. (2005) An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells. Biochemistry 44:2021-9
Kasravi, F Behzad; Lee, Diana H; Weisgraber, Karl et al. (2005) Lipoprotein-bound endotoxin exerts an immunomodulatory effect on hepatocytes through the lipid A domain of LPS. J Endotoxin Res 11:19-24
Bergo, Martin O; Gavino, Bryant J; Hong, Christine et al. (2004) Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. J Clin Invest 113:539-50
Bergo, Martin O; Lieu, Hsiao D; Gavino, Bryant J et al. (2004) On the physiological importance of endoproteolysis of CAAX proteins: heart-specific RCE1 knockout mice develop a lethal cardiomyopathy. J Biol Chem 279:4729-36
Raffai, Robert L; Weisgraber, Karl H (2003) Cholesterol: from heart attacks to Alzheimer's disease. J Lipid Res 44:1423-30
Raffai, Robert L; McPherson, Ruth; Weisgraber, Karl H et al. (2003) Antibody phenotyping test for the human apolipoprotein E2 isoform. Clin Chem 49:1524-6
Liao, Wei; Hui, To Y; Young, Stephen G et al. (2003) Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER. J Lipid Res 44:978-85

Showing the most recent 10 out of 168 publications